Clinical Trials Logo

Constriction, Pathologic clinical trials

View clinical trials related to Constriction, Pathologic.

Filter by:

NCT ID: NCT03084367 Completed - Clinical trials for Coronary Artery Disease

Physiologic Assessment of Coronary Stenosis Following PCI

DEFINE PCI
Start date: June 20, 2017
Phase:
Study type: Observational

This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).

NCT ID: NCT03080519 Not yet recruiting - Clinical trials for Renal Artery Obstruction

Endovascular Therapy for Renal Artery Stenosis in China

ETRAS-China
Start date: April 2017
Phase: N/A
Study type: Interventional

A multicenter prospective registry planned to recruit more than 5 000 patients with renal artery stenosis was carried out in China. This primary purpose of this study was to evaluate the safety and efficacy of renal artery revascularization in the real world. The secondary purpose was to investigate the etiologic distribution of renal artery stenosis and optimize the indications for renal artery revascularization.

NCT ID: NCT03069664 Recruiting - Pancreatic Cancer Clinical Trials

Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer

Start date: November 17, 2017
Phase: N/A
Study type: Interventional

Patients with pancreatic cancer often suffer from chronic abdominal pain, weight loss and decreased quality of life. The patients also often need pancreatic enzyme supplements. In this prospective study the aim is to see whether patients undergoing palliative pancreatic duct drainage will experience less chronic abdominal pain and a higher quality of life than patients with the same diagnosis without the procedure. The study also investigates whether the nutritional state of the patients with palliative stents remains better than in the control group.

NCT ID: NCT03065452 Completed - Clinical trials for Lumbar Stenosis, Familial

Sagittal Imbalance and Lumbar Stenosis Surgery: Decompression Without Implant

CLE/EOS
Start date: November 2014
Phase: N/A
Study type: Observational

Lumbar stenosis (LSS) is the most frequent degenerative lumbar disease and is the most frequent indication for spinal surgery. When non-invasive treatments fail, decompression surgery is the gold standard therapy for the majority of patients and generally improves symptoms. However, few studies have investigated the improvement in posture (radiological parameters) after surgery. In lumbar stenosis, patients may present a forward leaning posture (to relieve pain), which is responsible for sagittal imbalance. The aim of this prospective study was to evaluate the repercussions of decompression surgery on sagittal balance and to compare these with aux clinical results. investigators included patients operated on for isolated lumbar canal stenosis.

NCT ID: NCT03057353 Active, not recruiting - Clinical trials for Lumbar Spinal Stenosis

Risk Factors for Ligamentum Flavum Hypertrophy in Lumbar Spinal Stenosis Patients

Start date: May 2012
Phase: N/A
Study type: Observational

To measure ligamentum flavum thickness in patients with different nationalities, sexes, heights, ages, and weights from Xinjiang Uygur Autonomous Region of China with CT, explore the correlation between various factors and ligamentum flavum thickness, provide reference for pedicle screw placement and lumbar decompression surgery, develop individualized surgical programs, and can effectively reduce the incidence of unnecessary postoperative complications induced by misplacement.

NCT ID: NCT03054324 Recruiting - Coronary Stenosis Clinical Trials

Validation of a Predictive Model of Coronary Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis

FFRB
Start date: September 2, 2016
Phase:
Study type: Observational

Coronary fraction flow reserve (FFR), the ratio of the mean coronary pressure distal to a coronary stenosis to the mean aortic pressure during maximal coronary blood flow (hyperemia), defines the hemodynamic significance of coronary artery narrowing. Noninvasive assessment of FFR via a combination of computational fluid dynamics (CFD) and coronary CT angiography CCTA (the so-called FFRCT) has potential. Coronary computed tomographic angiography is a noninvasive test for diagnosis of anatomic coronary stenosis (i.e., narrowing of a blood vessel). A new analytical model of FFR from the general Bernoulli equation (conservation of energy) (FFRB) is simple and has potential. A collaborator group has recently developed a new analytical model to quantify pressure drop, and hence FFR, based on lesion dimensions (i.e., the cross-section area along the lesion and the length of lesion) and coronary flow, with no empirical parameters. The investigators hypothesize that this new model will allow quantification of FFR (FFRB) in a cohort of human patients with intermediate coronary stenosis. The study will compare FFRB with invasive FFR measurements from invasive coronary angiography (ICAG).

NCT ID: NCT03051360 Not yet recruiting - Clinical trials for Aortic Valve Stenosis

PCSK9 Inhibitors in the Progression of Aortic Stenosis

Start date: June 1, 2017
Phase: Phase 2
Study type: Interventional

Investigators plan evaluate whether PCSK9 inhibitors, a medication that can lower lipoprotein(a) and control dyslipidemia, can inhibit the progression of aortic stenosis, through a randomized controlled trial.

NCT ID: NCT03051334 Recruiting - Clinical trials for Aortic Valve Stenosis

Ascending Aortic Dilation in BiAV After TAVR

Start date: January 1, 2007
Phase: N/A
Study type: Observational

This study sought to evaluate changes in ascending aorta size after transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BiAV) compared with patients with tricuspid aortic valve (TAV).

NCT ID: NCT03048955 Withdrawn - Clinical trials for Spinal Stenosis, Lumbar Region With Neurogenic Claudication

Assessing Superion Clinical Endpoints vs. Decompression

ASCEND
Start date: February 8, 2017
Phase: N/A
Study type: Interventional

PURPOSE: The primary purpose of this study is to demonstrate that the Composite Clinical Success of the study group receiving the Superion® IDS is not inferior to the success rate observed in the study group treated by direct decompression at 60 months follow-up. Secondarily, the trial is intended to establish that Composite Clinical Success of the study group receiving the Superion® IDS at 24 months is not inferior to the success rate observed at 24 months in patients treated with the Superion® IDS in the original IDE trial. Thirdly, the trial is intended to establish that Composite Clinical Success of the population receiving the Superion® IDS in this trial at 24 months is not inferior to the success rate observed at 24 months in patients treated with direct decompression.

NCT ID: NCT03042104 Active, not recruiting - Heart Diseases Clinical Trials

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

EARLY TAVR
Start date: July 12, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis.